...
首页> 外文期刊>Ophthalmology >Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration.
【24h】

Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration.

机译:年龄相关性黄斑变性患者的隐匿性小凹下脉络膜新生血管的经瞳孔热疗。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: To evaluate the efficacy of transpupillary thermotherapy for the treatment of occult subfoveal choroidal neovascularization (CNV) in patients with age-related macular degeneration. DESIGN: A retrospective, noncomparative case series. PARTICIPANTS: Sixteen eyes of 15 consecutive patients who presented with occult subfoveal choroidal neovascularization secondary to age-related macular degeneration. INTERVENTION: After informed consent was obtained, 16 eyes of 15 patients were treated with transpupillary thermotherapy. All patients underwent pretreatment fluorescein angiography and were deemed untreatable by the Macular Photocoagulation Study standard. Transpupillary thermotherapy was delivered using a diode laser at 810 nm. A variable spot size of 1.2 mm, 2.0 mm, or 3.0 mm was used depending on the size of CNV. The diode laser was delivered through a contact lens, and treatment was initiated in one spot for 60 seconds' duration at a power range between 360 and 1000 mW. The end point was an area of no visible color change to a light-gray appearance. MAIN OUTCOME MEASURES: In all eyes, outcome was assessed by Snellen chart visual acuity and clinical examination. In 10 of 16 eyes, preoperative and postoperative fluorescein angiography and optical coherence tomography were available. In the remaining 6 of 16 eyes, exudation was measured by postoperative clinical examination alone. RESULTS: Three eyes (19%) showed a two-or-more-line improvement in visual acuity over a period of 6 to 25 months. Mean follow-up was 13 months. Visual acuity remained stable (no change or one-line improvement) in nine treated eyes (56%). The remaining four eyes (25%) showed a decline (equal to one-line worsening or greater) in visual acuity. Fifteen eyes (94%) demonstrated decreased exudation on fluorescein angiography, optical coherence tomography, and/or clinical examination. CONCLUSIONS: Transpupillary thermotherapy shows no deleterious side effects in treating occult subfoveal choroidal neovascularization. A randomized, prospective study is necessary to evaluate treatment efficacy.
机译:目的:评价经瞳孔温热疗法治疗年龄相关性黄斑变性的隐匿性小凹下脉络膜新生血管的疗效。设计:回顾性,非比较性案例系列。参与者:15例连续的16眼患者,这些患者因年龄相关性黄斑变性继发隐匿性小凹下脉络膜新生血管。干预:在获得知情同意后,对15例患者的16眼进行了经瞳孔热疗。所有患者均接受了预处理的荧光素血管造影术,黄斑光凝研究标准认为不可治愈。使用810 nm的二极管激光器进行经瞳孔热疗。根据CNV的大小,可以使用1.2 mm,2.0 mm或3.0 mm的可变光斑尺寸。二极管激光器通过隐形眼镜传送,并在360至1000 mW的功率范围内在一个点处开始治疗60秒。终点是没有可见的颜色变化为浅灰色外观的区域。主要观察指标:在所有眼睛中,均通过Snellen视力表视力和临床检查评估结果。在16只眼中的10只眼中,术前和术后可进行荧光素血管造影和光学相干断层扫描。在16只眼的其余6只眼中,仅通过术后临床检查即可测量渗出情况。结果:在6到25个月的时间内,三只眼(19%)的视力提高了2倍或更多。平均随访13个月。九只接受治疗的眼睛(56%)的视力保持稳定(无变化或单线改善)。其余四只眼睛(25%)显示视力下降(等于单线恶化或更大)。在荧光素血管造影,光学相干断层扫描和/或临床检查中,有十五只眼睛(94%)表现出渗出减少。结论:经瞳孔热疗未显示隐匿性小凹下脉络膜新生血管的有害副作用。一项随机,前瞻性研究对于评估治疗效果是必要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号